We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Bladder Cancer

Journal Scan / Research · August 03, 2022

Effect of Novel Intravesical Attenuated Mycobacterial Vaccine on BCG-Unresponsive Bladder Tumors

Journal for immunotherapy of cancer


Additional Info

Journal for immunotherapy of cancer
Novel intravesical bacterial immunotherapy induces rejection of BCG-unresponsive established bladder tumors
J Immunother Cancer 2022 Jul 01;10(7)xx, E Moreo, S Uranga, A Picó, AB Gómez, D Nardelli-Haefliger, C Del Fresno, I Murillo, E Puentes, E Rodríguez, M Vales-Gómez, J Pardo, D Sancho, C Martín, N Aguilo

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading